Poolbeg Pharma PLC (AIM:POLB)
London · Delayed Price · Currency is GBP · Price in GBX 4.800
+0.300 (6.67%)
Apr 15, 2026, 4:29 PM GMT
Poolbeg Pharma Market Cap
Poolbeg Pharma has a market cap or net worth of 32.43 million as of April 15, 2026. Its market cap has increased by 135.89% in one year.
Market Cap
32.43M
Enterprise Value
22.47M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
4.80
Market Cap Chart
Since July 19, 2021, Poolbeg Pharma's market cap has decreased from 53.75M to 32.43M, a decrease of -39.66%. That is a compound annual growth rate of -10.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 14, 2026 | 31.73M | 13.78% |
| Dec 31, 2025 | 27.89M | -21.44% |
| Dec 31, 2024 | 35.50M | -21.55% |
| Dec 29, 2023 | 45.25M | 49.59% |
| Dec 30, 2022 | 30.25M | -36.32% |
| Dec 31, 2021 | 47.50M | -11.63% |
| Jul 19, 2021 | 53.75M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| 4basebio | 78.16M |
| hVIVO | 59.19M |
| Ondine Biomedical | 58.45M |
| Hemogenyx Pharmaceuticals | 55.58M |
| Faron Pharmaceuticals Oy | 51.41M |
| ImmuPharma | 29.42M |
| Sareum Holdings | 25.54M |
| SkinBioTherapeutics | 25.27M |